Challenging and still unsolved problems in kidney transplantation are risk stratification and the treatment of humoral rejection. antibodies are produced is unknown. In this review, we will address these questions, provide an overview of other diseases in which these antibodies are prevalent, and describe the physiological role of RhoGDI2 itself. If the mechanism and impact… Continue reading Challenging and still unsolved problems in kidney transplantation are risk stratification and the treatment of humoral rejection